A simple blood test may predict the risk of progressive heart and kidney disease in people with Type 2 diabetes and kidney disease, according to new research published today in the American Heart Association’s flagship journal Circulation.
Kyowa Kirin Co Ltd Patent: Monoclonal Antibody Inhibiting CCR1 Activation
Share this article According to GlobalData’s company profile on Kyowa Kirin, was a key innovation area identified from patents. Kyowa Kirin‘s grant share as of